35986841_10216840653711318_1105697261150535680_n
Normal view MARC view ISBD view

Impact of mircoRNA-125b expression as prognostic factor in acute myeloid leukemia تقييم المسار المعتمد ل 1-PVT-Lnc في تشخيص (21:8(t المرتبط باللوكيميا النخاعية الحادة // GP // Dr. Nashwa Nagy // Dr. Ahmed Nada (2017-2018)

By: Ashraqat Sami Ahmed 153515.
Material type: materialTypeLabelBookSeries: BIOTECHNOLOGY DISTINGUISHED PROJECTS 2018. Publisher: Giza MSA 2018Description: 79 P. 30 CM.Subject(s): Myeloid Leukemia | BiotechnologyDDC classification: 570 Online resources: FULL TEXT PRESS HERE Summary: Abstract: Acute myeloid leukemia (AML) associated with t(8;21) is the most common karyotype abnormality in acute myeloid leukemia; it is found in approximately 10 - 22% of AML class M2 cases with maturation. The prognosis of t(8;21) associated AML is controversial; whereas; some studies considered it favorable as it often associated with a good respond to therapy , high rate to complete remission with prolonged survival with free of disease, other studies investigated that t(8;21) AML have adverse prognosis with poor outcome, less responsive to treatment, low overall survival and fast rate of relapsing. The current study evaluated the role of lnc-PVT- 1/miR-1204/c-Myc pathway "RNA-DNA cross-link" as a predicator in stratification of high risk t(8;21) associated AML. Moreover, it evaluated the impact of these studied biomarkers on disease outcome using Syber green based qPCR. The study showed that peripheral blood levels of lnc-PVT-1 is upregulated 6.5 folds in t(8;21)- AML with highly significant when it compared to control group; Lnc-RVT1 is significantly correlated with miR-1204 and c-Myc. In addition; the upregulation of PVT1 is associated with poor disease outcome and short disease free survival. Therefore, it was found that lnc-PVT1 dependent pathway as a prognostic marker in t(8;21) associated AML and it represents a wide domain for research to reach a solid evidence and implications in the clinical field.
List(s) this item appears in: Biotechnology Distinguished Graduation Projects - Year 2017 / 2018
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Notes Date due Barcode
Distinguished Graduation Projects Distinguished Graduation Projects Soft Copy located on library Cataloge GP401BIO2018 (Browse shelf) Available 570 81803

Biotechnology

Abstract:
Acute myeloid leukemia (AML) associated with t(8;21)
is the most common karyotype abnormality in acute
myeloid leukemia; it is found in approximately 10 - 22% of
AML class M2 cases with maturation. The prognosis of t(8;21) associated AML is
controversial; whereas; some studies considered it favorable as it often associated
with a good respond to therapy , high rate to complete remission with prolonged
survival with free of disease, other studies investigated that t(8;21) AML have
adverse prognosis with poor outcome, less responsive to treatment, low overall
survival and fast rate of relapsing. The current study evaluated the role of lnc-PVT-
1/miR-1204/c-Myc pathway "RNA-DNA cross-link" as a predicator in stratification
of high risk t(8;21) associated AML. Moreover, it evaluated the impact of these
studied biomarkers on disease outcome using Syber green based qPCR. The study
showed that peripheral blood levels of lnc-PVT-1 is upregulated 6.5 folds in t(8;21)-
AML with highly significant when it compared to control group; Lnc-RVT1 is
significantly correlated with miR-1204 and c-Myc. In addition; the upregulation of
PVT1 is associated with poor disease outcome and short disease free survival.
Therefore, it was found that lnc-PVT1 dependent pathway as a prognostic marker
in t(8;21) associated AML and it represents a wide domain for research to reach a
solid evidence and implications in the clinical field.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer